The efficacy of tranexamic acid in decreasing bleeding during transurethral resection of prostate: A systematic review and meta-analysis
Abstract
Transurethral resection of the prostate (TURP) remains the standard surgical treatment for benign prostatic hyperplasia. Perioperative bleeding is a major concern and may lead to blood transfusion, prolonged catheterization, and extended hospital stay. Tranexamic acid (TXA), an antifibrinolytic agent, has been used to reduce surgical bleeding; however, its efficacy in TURP remains controversial. This systematic review and meta-analysis aimed to evaluate the effectiveness of TXA in reducing perioperative bleeding and improving operative outcomes in patients undergoing TURP.
A systematic search of multiple electronic databases was conducted to identify controlled trials comparing TXA with placebo or no intervention in patients undergoing TURP. Eligible studies were required to report hemoglobin change as the primary outcome. Data were pooled using mean differences (MD) with 95% confidence intervals (CI) were calculated.
Thirteen studies comprising 1127 participants met the inclusion criteria. Meta-analysis demonstrated a significantly smaller decline in hemoglobin levels in the TXA group compared with control (MD, −0.62; 95% CI, −0.93 to −0.32;
P
< .0001). TXA significantly reduced operative blood loss (MD, −104.35 mL; 95% CI, −163.35 to −45.41;
P
= .0005), shortened operative time (MD, −6.95 minutes, 95% CI, −11.62 to −2.27;
P
= .004), and decreased catheterization duration (MD, −0.18 days; 95% CI, −0.36 to −0.01;
P
= 0.04).
TXA appears to significantly reduce perioperative…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 1,127 participants or records.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.